EBOS GROUP LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.3 NZD | -3.24% |
|
-1.12% | -3.38% |
| Apr. 26 | New Zealand Shares Drop on Consumer Pessimism; Ebos Group Falls 3% After Appointing New CFO | MT |
| Apr. 25 | Ebos Group Appoints New CFO | MT |
ETFs positioned on EBOS Group Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.06% | 3,859 M€ | +18.82% | - | |
| 0.06% | 469 M€ | -2.05% | - | |
| 0.05% | 4 M€ | -.--% | - | |
| 0.02% | 10 M€ | -3.35% | - | |
| 0.02% | 284 M€ | -.--% | ||
| 0.01% | 7 M€ | +1.95% | - | |
| 0.01% | 607 M€ | +0.05% | - | |
| 0.01% | 1,166 M€ | +0.26% | - | |
| 0.01% | 34 M€ | +6.71% | - | |
| 0.00% | 302 M€ | +3.80% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 17 M€ | +1.44% | - | |
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 108 M€ | +2.03% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 8 M€ | -0.60% | - | |
| 0.00% | 52 M€ | -0.60% | - |
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is a marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, own brands, retail healthcare, pharmacy, hospital and logistic services and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. It sources and supplies a range of surgical, medical, and pharmaceutical products. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics and Clinect.
Sector
Pharmaceuticals
Calendar
2024-08-19
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
34.3
NZD
Average target price
37.94
NZD
Spread / Average Target
+10.62%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -3.38% | 3.93B | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
- Stock Market
- Equities
- EBO Stock
- Funds and ETFs EBOS Group Limited
